| 16-May-13 08:25AM | New Validation and Clinical Outcome Data From Several Studies on Nanosphere's Gram-Positive and Gram-Negative Blood Culture Tests to Be Presented at ASM 2013 Marketwired |
| 08:25AM | New Validation and Clinical Outcome Data From Several Studies on Nanosphere's Gram-Positive and Gram-Negative Blood Culture Tests to Be Presented at ASM 2013 Marketwire |
| 15-May-13 08:00AM | Nanosphere to Present at UBS Global Healthcare Conference Marketwired |
| 08:00AM | Nanosphere to Present at UBS Global Healthcare Conference Marketwire |
| 14-May-13 01:04PM | NANOSPHERE INC Financials EDGAR Online Financials +11.47% |
| 08:25AM | Bulls pile into Take-Two Interactive optionMONSTER |
| 08:09AM | BRIEF-Nanosphere shares up 18 pct premarket at Reuters |
| 13-May-13 06:56PM | On The Fly: After Hours Movers at theflyonthewall.com |
| 04:01PM | InPlay: Nanosphere announces distribution and collaboration agreement with Hitachi High-Technologies Briefing.com |
| 04:01PM | Nanosphere Announces Distribution and Collaboration Agreement With Hitachi High-Technologies Corporation Marketwired |
| 04:01PM | Nanosphere Announces Distribution and Collaboration Agreement With Hitachi High-Technologies Corporation Marketwire |
| 09:37AM | NANOSPHERE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online |
| 08-May-13 05:07PM | Nanosphere's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 11:00AM | NANOSPHERE INC Earnings Call scheduled for 11:00 am ET today CCBN |
| 08:48AM | InPlay: Nanosphere reports in-line results; beats on revs; reaffirms FY13 guidance; secures financing Briefing.com |
| 08:40AM | Nanosphere Announces Record First Quarter Revenues and Strengthens Balance Sheet With $27 Million Debt and Equity Financing Marketwired |
| 08:40AM | Nanosphere Announces Record First Quarter Revenues and Strengthens Balance Sheet With $27 Million Debt and Equity Financing Marketwire |
| 07:36AM | NANOSPHERE INC Earnings Call scheduled for 11:00 am ET today CCBN |
| 07:07AM | Q1 2013 NANOSPHERE INC Earnings Release - Before Market Open CCBN |
| 01:46AM | NANOSPHERE INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial EDGAR Online |
| 01:02AM | NANOSPHERE INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07-May-13 10:02AM | NANOSPHERE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligat EDGAR Online |
| 30-Apr-13 08:00AM | Nanosphere to Release First Quarter 2013 Results and Hold Investor Conference Call on Wednesday, May 8, 2013 Marketwired |
| 08:00AM | Nanosphere to Release First Quarter 2013 Results and Hold Investor Conference Call on Wednesday, May 8, 2013 Marketwire |
| 25-Apr-13 04:29PM | Nanosphere announces Ken Bahk, Ph.D. named as Chief Strategy Officer, CTO departs theflyonthewall.com |
| 04:06PM | InPlay: Nanosphere announces Tim Patno departing as Chief Technology Officer Briefing.com |
| 04:02PM | Nanosphere Welcomes Ken Bahk, Ph.D. as Chief Strategy Officer and Announces Other Organizational Changes Marketwired |
| 04:02PM | Nanosphere Welcomes Ken Bahk, Ph.D. as Chief Strategy Officer and Announces Other Organizational Changes Marketwire |
| 09:04AM | NANOSPHERE INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and EDGAR Online |
| 22-Apr-13 04:42PM | Cowen upbeat on Nanosphere; shares rise AP +7.60% |
| 02-Apr-13 02:36PM | 4 Health Care Stocks Under $10 to Watch at TheStreet |
| 13-Mar-13 09:00AM | InPlay: Nanosphere Obtains CE Mark for Gram-Negative Blood Culture Test Briefing.com |
| 08:08AM | Nanosphere obtains CE IVD mark for Gram-Negative Blood Culture Test theflyonthewall.com |
| 08:00AM | Nanosphere Obtains CE Mark for Gram-Negative Blood Culture Test Marketwired |
| 08:00AM | Nanosphere Obtains CE Mark for Gram-Negative Blood Culture Test Marketwire |
| 06-Mar-13 01:04PM | NANOSPHERE INC Financials EDGAR Online Financials |
| 04-Mar-13 02:54PM | 4 Healthcare Stock Stories for Start-of-the-Week Wellness at Wall St. Cheat Sheet |
| 12:44PM | Four Analyst Upgrades that I Would Not Chase at Motley Fool |
| 01-Mar-13 09:41AM | 2 $2 Biotech Stocks Insiders Are Buying at Seeking Alpha +13.85% |
| 28-Feb-13 04:27PM | NANOSPHERE INC Files SEC form 10-K, Annual Report EDGAR Online |
| 22-Feb-13 08:30AM | Nanosphere to Present at the Cowen and Company 33rd Annual Health Care Conference Marketwired |
| 08:30AM | Nanosphere to Present at the Cowen and Company 33rd Annual Health Care Conference Marketwire |
| 21-Feb-13 09:57AM | Nanosphere Director Buys 50K Shares and 4 Insider Buys to Note at Wall St. Cheat Sheet -6.86% |
| 15-Feb-13 06:07PM | Nasdaq stocks posting largest volume increases AP |
| 14-Feb-13 06:02PM | Nasdaq stocks posting largest volume increases AP -32.20% |
| 09:17AM | New Star Analyst Rankings for Nanosphere, Inc. StarMine |
| 13-Feb-13 10:13PM | Nanosphere's CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 05:00PM | NANOSPHERE INC Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:05PM | NANOSPHERE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 04:00PM | Nanosphere Announces Record Revenues and Placements, and Key Leadership Changes Marketwire |
| 07:07AM | Q4 2012 NANOSPHERE INC Earnings Release - After Market Close CCBN |
| 05-Feb-13 10:07AM | Nanosphere to Release Q4 and Full Year 2012 Results and Hold Investor Call on Wednesday, February 13 GlobeNewswire +5.00% |
| 02:43AM | Insider Buying Trends: Are These Cash Rich Companies Ready To Rally? at Seeking Alpha |
| 01-Feb-13 01:22PM | 3 Highly Shorted Stocks Under $5 Being Bought By Hedge Funds at TheStreet |
| 04-Jan-13 10:48AM | Insider Buying Trends: Are These Cash Rich Companies Ready To Rally? at Seeking Alpha |
| 03-Jan-13 10:26AM | The Market Awaits Financial Results From Nanosphere's Gram-Positive Test at Seeking Alpha |
| 02-Jan-13 04:34PM | NANOSPHERE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 28-Dec-12 04:44PM | NANOSPHERE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 10-Dec-12 03:38PM | InPlay from Briefing.com Briefing.com |
| 03:28PM | Nanosphere receives FDA clearance for C. difficile test theflyonthewall.com |
| 03:27PM | InPlay: Nanosphere confirms it received FDA clearance for C. difficile test Briefing.com |
| 03:26PM | Nanosphere Receives FDA Clearance for C. difficile Test GlobeNewswire |
| 29-Nov-12 09:47AM | Nanosphere to Present at Canaccord Genuity Medical Technology & Diagnostics Forum GlobeNewswire +6.18% |
| 08:35AM | Video: Nanosphere's Breakthrough Technology Allowing Earlier Detection and More Targeted Treatment Thomson Reuters ONE |
| 21-Nov-12 10:51AM | Nanosphere to Present at Piper Jaffray 24th Annual Healthcare Conference GlobeNewswire +5.02% |
| 16-Nov-12 01:04PM | NANOSPHERE INC Financials EDGAR Online Financials -5.47% |
| 13-Nov-12 01:40PM | Nanosphere's Management Presents at Lazard Capital Markets Healthcare Conference (Transcript) at Seeking Alpha |
| 08:31AM | Falling prices weigh on AK Steel optionMONSTER |
| 08:31AM | Dropping prices weigh down AK Steel optionMONSTER |
| 07:50AM | Nanosphere receives FDA clearance to market its CYP2C19 theflyonthewall.com |
| 07:47AM | InPlay: Nanosphere receives FDA clearance to market test for detection of CYP2C19 mutations affecting drug metabolism Briefing.com |
| 07:45AM | Nanosphere Receives FDA Clearance to Market Test for Detection of CYP2C19 Mutations Affecting Drug Metabolism GlobeNewswire |
| 08-Nov-12 09:33AM | New Star Analyst Rankings for Nanosphere, Inc. StarMine -5.50% |
| 07-Nov-12 10:52PM | Nanosphere's CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 05:00PM | NANOSPHERE INC Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:06PM | NANOSPHERE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:03PM | NANOSPHERE INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 04:01PM | Nanosphere Announces Third Quarter 2012 Results GlobeNewswire |
| 07:36AM | NANOSPHERE INC Earnings Call scheduled for 5:00 pm ET today CCBN |
| 07:07AM | Q3 2012 NANOSPHERE INC Earnings Release - After Market Close CCBN |
| 06-Nov-12 09:29AM | Nanosphere to Present at Lazard Capital Markets and Stephens Inc. Investor Conferences GlobeNewswire |
| 01-Nov-12 06:22PM | InPlay: Nanosphere's bloodstream infection test designated moderate complexity by FDA Briefing.com |
| 06:20PM | Nanosphere's Bloodstream Infection Test Designated Moderate Complexity by FDA GlobeNewswire |
| 26-Oct-12 10:43AM | Nanosphere to Release Q3 2012 Results and Hold Investor Call on Wednesday, November 7 GlobeNewswire |
| 22-Oct-12 10:33AM | Nanosphere says test accurately detects targets in study at theflyonthewall.com |
| 10:29AM | Nanosphere Test Accurately Detects a Broad Panel of Bacterial Targets and Resistance Determinants Directly From Blood Culture GlobeNewswire |
| 10-Oct-12 05:16PM | NANOSPHERE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 05:15PM | Nanosphere, Inc. Appoints Roy N. Davis to Board of Directors GlobeNewswire |
| 04-Oct-12 12:08PM | 5 Stocks Under $10 Set to Soar at TheStreet |
| 09:49AM | Long-Term BioTech Play at Motley Fool |
| 24-Sep-12 10:04PM | 5 of Last Week's Biggest Winners at Motley Fool |
| 03:04PM | 3 Low-Debt Healthcare Stocks Loaded With Cash at Seeking Alpha |
| 21-Sep-12 09:24AM | Nanosphere to Present at Craig-Hallum Alpha Select Conference GlobeNewswire +10.50% |
| 18-Sep-12 07:13AM | Nanosphere: A Low-Risk, High-Growth Diagnostic Stock at TheStreet +12.26% |
| 13-Sep-12 11:29AM | FDA Clears GenMark's Newest Test Zacks |
| 10-Sep-12 11:00AM | Nanosphere to Present at UBS Global Life Sciences Conference GlobeNewswire |
| 29-Aug-12 12:04PM | Nanosphere to Present at Rodman & Renshaw Annual Global Investment Conference GlobeNewswire |
| 28-Aug-12 02:18PM | 8 Stocks Under $10 Surging Higher at TheStreet |
| 27-Aug-12 11:48AM | 4 High-Liquid Healthcare Stocks Strongly Favored By Analysts at Seeking Alpha +6.78% |
| 15-Aug-12 01:57PM | Healthcare review: Halozyme Therapeutics & Arena Jumps, AEterna Zentaris Falls Thomson Reuters ONE |
|
| Nanosphere, Inc. develops, manufactures, and markets molecular diagnostics platform, the Verigene System that enables genomic and protein testing on a single platform. Its Verigene System includes a bench-top molecular diagnostics workstation with nanoparticle technology that provides the ability to run multiple tests simultaneously on the same sample. The Verigene System is used for testing infectious disease assays, human and pharmacogenetic assays, and ultra-sensitive protein assays. The company serves hospital-based laboratories and academic research institutions in the United States. Nanosphere, Inc. was founded in 1998 and is headquartered in Northbrook, Illinois. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Mirkin Chad A. | Director | Feb 21 | Buy | 1.96 | 10,000 | 19,600 | 272,570 | Feb 22 07:19 PM | | ROSENBERG SHELI Z | Director | Feb 19 | Buy | 1.97 | 50,000 | 98,745 | 154,812 | Feb 20 09:58 AM | | SLEZAK MARK | Director | Jul 19 | Buy | 2.40 | 1,000,000 | 2,400,000 | 5,006,136 | Jul 23 04:08 PM | | SLEZAK MARK | Director | Jun 15 | Buy | 2.05 | 229,746 | 470,152 | 2,274,096 | Jun 18 04:13 PM | | SLEZAK MARK | Director | Jun 14 | Buy | 1.98 | 79,329 | 157,048 | 2,044,350 | Jun 18 04:13 PM | | SLEZAK MARK | Director | Jun 13 | Buy | 1.95 | 40,000 | 78,012 | 1,965,021 | Jun 14 04:07 PM | | SLEZAK MARK | Director | Jun 12 | Buy | 1.98 | 10,000 | 19,750 | 1,925,021 | Jun 14 04:07 PM | | SLEZAK MARK | Director | Jun 11 | Buy | 1.95 | 5,000 | 9,738 | 1,915,021 | Jun 12 04:10 PM | | SLEZAK MARK | Director | Jun 08 | Buy | 1.96 | 20,000 | 39,110 | 1,910,021 | Jun 12 04:10 PM | | SLEZAK MARK | Director | Jun 07 | Buy | 1.90 | 13,116 | 24,857 | 1,890,021 | Jun 08 04:38 PM | | SLEZAK MARK | Director | Jun 06 | Buy | 1.85 | 15,000 | 27,740 | 1,876,905 | Jun 08 04:38 PM | | SLEZAK MARK | Director | Jun 05 | Buy | 1.75 | 317,500 | 554,641 | 1,861,905 | Jun 06 05:25 PM | | SLEZAK MARK | Director | Jun 04 | Buy | 1.75 | 25,000 | 43,745 | 1,544,405 | Jun 06 05:25 PM | | SLEZAK MARK | Director | Jun 01 | Buy | 1.71 | 88,900 | 152,348 | 1,519,405 | Jun 04 04:13 PM | | SLEZAK MARK | Director | May 31 | Buy | 1.69 | 30,000 | 50,814 | 1,430,505 | Jun 04 04:13 PM | | SLEZAK MARK | Director | May 29 | Buy | 1.69 | 10,000 | 16,932 | 1,400,505 | May 31 04:05 PM | | SLEZAK MARK | Director | May 25 | Buy | 1.70 | 5,505 | 9,382 | 1,390,505 | May 29 04:13 PM | | SLEZAK MARK | Director | May 24 | Buy | 1.71 | 35,000 | 59,700 | 1,385,000 | May 29 04:13 PM |
|
